A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations
- PMID:20046772
- PMCID: PMC2792560
- DOI: 10.4103/0250-474X.44595
A Study on Improvement of Solubility of Rofecoxib and its effect on Permeation of Drug from Topical Formulations
Abstract
Rofecoxib, a practically insoluble cox-2 selective nonsteroidal antiinflammatory agent was subjected to improvement in solubility by preparing its binary mixtures with beta cyclodextrin using various methods such as physical mixing, co-grinding, kneading with aqueous methanol and co-evaporation from methanol-water mixture. Characterization of the resulting binary mixtures by differential scanning calorimetry and X-ray diffraction studies indicated partial amorphization of the drug in its binary mixtures. In vitro dissolution studies exhibited remarkable increase in rate and extent of dissolution of the drug from its complexes with beta -cyclodextrin. Pure rofecoxib as well as its co-ground binary mixture were formulated as aqueous gels for topical application. In vitro skin permeation of rofecoxib from formulation containing rofecoxib-cyclodextrin complex was significantly higher (p<0.05) at 1, 2, 12, 18 and 24 hr as compared to formulation containing pure rofecoxib. This could be attributed to better solubility of binary mixture in the aqueous gel vehicle leading to greater concentration gradient between the vehicle and skin and hence higher flux of the drug.
Keywords: Rofecoxib; binary mixture; in vitro skin permeation; β-cyclodextrin.
Figures
Similar articles
- Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.Rawat S, Jain SK.Rawat S, et al.Pharmazie. 2003 Sep;58(9):639-41.Pharmazie. 2003.PMID:14531460
- Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.Semalty M, Panchpuri M, Singh D, Semalty A.Semalty M, et al.Curr Drug Discov Technol. 2014 Jun;11(2):154-61. doi: 10.2174/15701638113106660043.Curr Drug Discov Technol. 2014.PMID:24188445
- Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.Patel R, Patel M.Patel R, et al.Drug Discov Ther. 2010 Dec;4(6):442-52.Drug Discov Ther. 2010.PMID:22491310
- Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.Cirri M, Rangoni C, Maestrelli F, Corti G, Mura P.Cirri M, et al.Drug Dev Ind Pharm. 2005 Aug;31(7):697-707. doi: 10.1080/03639040500253694.Drug Dev Ind Pharm. 2005.PMID:16207617
- Rofecoxib.[No authors listed][No authors listed]2020 Mar 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.2020 Mar 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.PMID:31643940Free Books & Documents.Review.
References
- Connors EP, editor. Physicians’ Desk Reference. 55th ed. New Jersy, USA: Medical Economoics Company Inc; 2001. pp. 2049–50.
- Singh A, Singh B, Ahuja N. RXB: An update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. J Pharm Pharmacol. 2004;55:859–94. - PubMed
- Yener G, Gonullu U, Uner M, Degim T, Araman A. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of Celcecoxib through human skin. Pharmazie. 2003;58:330–3. - PubMed
- Barry BW. Dermatological Formulations- Percutaneous Absorption. New York: Marcel Dekker Inc; 1983. pp. 167–8.
- Bekerso J, Ujtendaal EV, Beijnen J, Bult A. Cyclodextrins in pharmaceutical field. Drug Develop Ind Pharm. 1991;17:1503–49.
Related information
LinkOut - more resources
Full Text Sources
Research Materials